Markets:

Overview

News

Currencies

International

Treasuries

Anavex Life Sciences Corp. - Common Stock (NQ:AVXL)

3.279 +0.079 (+2.47%)

Streaming Delayed Price Updated: 11:39 AM EDT, Aug 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Anavex Life Sciences Corp. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Anavex Life Sciences Stock Just Shot Up 7% Today – Here’s An Important Update ↗

October 02, 2025

Via Stocktwits

Anavex Life Sciences Stock Rises After Experimental Alzheimer’s Drug Slows Cognitive Decline In Study ↗

September 09, 2025

After 48 weeks, patients receiving 30 mg once-daily oral Blarcamesine demonstrated barely detectable cognitive decline, the company said.

Via Stocktwits

Anavex Life Pre-Treatment Prevented Cognitive Impairment In Animal Model of Alzheimer's Disease, New Publication Shows ↗

August 20, 2025

Anavex published data showing blarcamesine prevented amyloid-related brain damage in mice, supporting SIGMAR1 as a target for Alzheimer's prevention.

Via Benzinga

What to Expect from Anavex Life Sciences's Earnings ↗

August 11, 2025

Via Benzinga

Anavex Life Sciences: Early Blarcamesine Treatment Cuts Alzheimer's Progression by 20 Months ↗

July 31, 2025

Anavex reported that early use of blarcamesine in Alzheimer's trials led to sustained cognitive and functional improvements over 4 years.

Via Benzinga

Anavex Life Sciences Stock Falls After Hours On $300M Raise Plan; Retail Traders Think It’s A ‘Smart’ Move ↗

July 15, 2025

Via Stocktwits

An Overview of Anavex Life Sciences's Earnings ↗

May 12, 2025

Via Benzinga

Earnings Scheduled For February 12, 2025 ↗

February 12, 2025

Via Benzinga

Earnings Scheduled For December 23, 2024 ↗

December 23, 2024

Via Benzinga

Earnings Scheduled For August 12, 2025 ↗

August 12, 2025

Via Benzinga

July 02, 2025

Check out the top five trending stocks on Stocktwits on Wednesday as U.S. equity markets recover after taking a breather on Tuesday.

Via Stocktwits

Topics Government

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 20, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

April 28, 2025

Via Benzinga

Anavex Life Sciences Reports Prolonged Benefit Data Of Blarcamesine In Early Alzheimer's Over 3 Years ↗

April 07, 2025

Anavex's blarcamesine shows sustained cognitive and functional benefit in early Alzheimer's patients after four years of continuous treatment.

Via Benzinga

Earnings Scheduled For May 13, 2025 ↗

May 13, 2025

Via Benzinga

Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday? ↗

February 12, 2025

A hotter-than-expected inflation report initially rattled markets on Wednesday morning, but investors found confidence to buy the dip, helping major indexes recover most losses by midday trading in New...

Via Benzinga

Topics Economy

Retail Investors Bet On Anavex Lifesciences Stock To Outperform Novavax, Rigel Pharma In Q1 On Alzheimer’s Drug Buzz ↗

January 14, 2025

The intense retail focus on Anavex reflects a broader market interest in neurodegenerative therapies, especially following disappointing trial results from Cassava Sciences’ simufilam.

Via Stocktwits

10 Health Care Stocks With Whale Alerts In Today's Session ↗

December 26, 2024

Via Benzinga

Kemper To Rally More Than 25%? Here Are 4 Top Analyst Forecasts For Thursday ↗

December 26, 2024

Via Benzinga

Short-Squeeze Target Anavex Life Sciences Gains Traction

December 26, 2024

Anavex Life Sciences stock market is set up for a short squeeze that could begin in early 2025 and increase the price by 400% or more.

Via MarketBeat

Greenfire Resources, Hut 8, TeraWulf, MicroStrategy And Other Big Stocks Moving Higher On Tuesday ↗

December 24, 2024

Via Benzinga

Honda Motor, Rumble, Despegar.com And Other Big Stocks Moving Higher On Monday ↗

December 23, 2024

Via Benzinga

US Stocks To Open Higher As Wall Street Expects 'Santa Rally' In Shortened Trading Week: MicroStrategy, Palantir, Qualcomm Among Stocks In Focus ↗

December 23, 2024

U.S. stock futures advanced on Monday as two out of the four major index futures were trading higher in premarket trade.

Via Benzinga

Dow Jumps Around 500 Points But Records 3rd Straight Weekly Loss: Greed Index Moves To 'Fear' Zone ↗

December 23, 2024

Via Benzinga

Topics Stocks

Qualcomm, Limoneira And 3 Stocks To Watch Heading Into Monday ↗

December 23, 2024

Via Benzinga

Friday's Top 5 Trending Stocks: What's The Scoop On GameStop, SoFi, Tesla? ↗

November 08, 2024

GameStop, SoFi, Tesla, Cassava Sciences and Anavex Life Sciences are the top five trending stocks on Stocktwits Friday. Here's a look at what's going on:

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 31, 2024

Via Benzinga

AVXL Stock Earnings: Anavex Life Sciences Misses EPS for Q3 2024 ↗

August 06, 2024

AVXL stock results show that Anavex Life Sciences missed analyst estimates for earnings per share the third quarter of 2024.

Via InvestorPlace

Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 29, 2024

Via Benzinga

Neurodegenerative Disease-Focused Anavex Life Sciences' Alzheimer's Candidate Slows Disease Progression By Almost 39% ↗

July 29, 2024

Anavex Life Sciences presented Phase 2b/3 study results at AAIC 2024, showing daily oral blarcamesine (ANAVEX2-73) significantly slows clinical decline in early Alzheimer's disease. The 48-week study...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Anavex Life Sciences Corp. - Common Stock (NQ:AVXL)

All News about Anavex Life Sciences Corp. - Common Stock

Starting at /week.